Manufacturers Life Insurance Company, The Kura Oncology, Inc. Transaction History
Manufacturers Life Insurance Company, The
- $109 Billion
- Q4 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 37,007 shares of KURA stock, worth $260,899. This represents 0.0% of its overall portfolio holdings.
Number of Shares
37,007
Previous 37,813
2.13%
Holding current value
$260,899
Previous $738,000
56.37%
% of portfolio
0.0%
Previous 0.0%
Shares
33 transactions
Others Institutions Holding KURA
# of Institutions
194Shares Held
77.3MCall Options Held
103KPut Options Held
106K-
Black Rock Inc. New York, NY6.97MShares$49.1 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY5.8MShares$40.9 Million0.71% of portfolio
-
Suvretta Capital Management, LLC New York, NY5.08MShares$35.8 Million1.84% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.82MShares$34 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA4.45MShares$31.4 Million0.63% of portfolio
About Kura Oncology, Inc.
- Ticker KURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 66,893,000
- Market Cap $472M
- Description
- Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...